UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tumour-associated macrophages exhibit anti-tumoural properties in Sonic Hedgehog medulloblastoma

Nature communications, 2019-06, Vol.10 (1), p.2410-2410, Article 2410

2019

Volltextzugriff (PDF)

A New Player in Neuroblastoma: YAP and Its Role in the Neuroblastoma Microenvironment

Cancers, 2021-09, Vol.13 (18), p.4650

2021

Volltextzugriff (PDF)

YAP-Mediated Repression of HRK Regulates Tumor Growth, Therapy Response, and Survival Under Tumor Environmental Stress in Neuroblastoma

Cancer research (Chicago, Ill.), 2020-11, Vol.80 (21), p.4741-4753

2020

Volltextzugriff (PDF)

Children's Oncology Group's 2023 blueprint for research: Neuroblastoma

Pediatric blood & cancer, 2023-09, Vol.70 (S6), p.e30572-n/a

2023

Volltextzugriff (PDF)

Circulating tumor DNA reveals mechanisms of lorlatinib resistance in patients with relapsed/refractory ALK-driven neuroblastoma

Nature communications, 2023-05, Vol.14 (1), p.2601-2601, Article 2601

2023

Volltextzugriff (PDF)

The yes-associated protein (YAP) is associated with resistance to anti-GD2 immunotherapy in neuroblastoma through downregulation of ST8SIA1

Oncoimmunology, 2023-12, Vol.12 (1), p.2240678-2240678

2023

Volltextzugriff (PDF)

Dissecting the cellular components of ex vivo γδ T cell expansions to optimize selection of potent cell therapy donors for neuroblastoma immunotherapy trials

Oncoimmunology, 2022-12, Vol.11 (1), p.2057012-2057012

2022

Volltextzugriff (PDF)

A 3D Bioprinted in vitro Model of Neuroblastoma Recapitulates Dynamic Tumor‐Endothelial Cell Interactions Contributing to Solid Tumor Aggressive Behavior

Advanced science, 2022-08, Vol.9 (23), p.e2200244-n/a

2022

Volltextzugriff (PDF)

Mitochondrial Bcl-2 Family Dynamics Define Therapy Response and Resistance in Neuroblastoma

Cancer research (Chicago, Ill.), 2012-05, Vol.72 (10), p.2565-2577

2012

Volltextzugriff (PDF)

Favorable Local Control From Consolidative Radiation Therapy in High-Risk Neuroblastoma Despite Gross Residual Disease, Positive Margins, or Nodal Involvement

International journal of radiation oncology, biology, physics, 2017-03, Vol.97 (4), p.806-812

2017

Volltextzugriff (PDF)

Ex vivo expanded patient-derived γδ T-cell immunotherapy enhances neuroblastoma tumor regression in a murine model

Oncoimmunology, 2019, Vol.8 (8), p.1593804-1593804

2019

Volltextzugriff (PDF)

Identification of a Novel NRG1 Fusion with Targeted Therapeutic Implications in Locally Advanced Pediatric Cholangiocarcinoma: A Case Report

Case reports in oncology, 2023-01, Vol.16 (1), p.255-261

2023

Volltextzugriff (PDF)

Phase II evaluation of sunitinib in the treatment of recurrent or refractory high‐grade glioma or ependymoma in children: a children's Oncology Group Study ACNS1021

Cancer medicine (Malden, MA), 2016-07, Vol.5 (7), p.1416-1424

2016

Volltextzugriff (PDF)

Mcl1 downregulation sensitizes neuroblastoma to cytotoxic chemotherapy and small molecule Bcl2-family antagonists

Cancer biology & therapy, 2009-08, Vol.8 (16), p.1587-1595

2009

Volltextzugriff (PDF)

Trends in analgesia‐sedation of pediatric patients receiving I‐131 MIBG in the pediatric intensive care unit: A report from the Pediatric Health Information System database

Pediatric blood & cancer, 2024-10, Vol.71 (10), p.e31205-n/a

2024

Volltextzugriff (PDF)

Select Bcl-2 antagonism restores chemotherapy sensitivity in high-risk neuroblastoma

BMC cancer, 2016-02, Vol.16 (96), p.97, Article 97

2016

Volltextzugriff (PDF)

A phase I study of sirolimus in combination with metronomic therapy (CHOAnome) in children with recurrent or refractory solid and brain tumors

Pediatric blood & cancer, 2020-04, Vol.67 (4), p.e28134-n/a

2020

Volltextzugriff (PDF)

Reduced ER–mitochondria connectivity promotes neuroblastoma multidrug resistance

The EMBO journal, 2022-04, Vol.41 (8), p.e108272-n/a

2022

Volltextzugriff (PDF)

A phase 1 study of simvastatin in combination with topotecan and cyclophosphamide in pediatric patients with relapsed and/or refractory solid and CNS tumors

Pediatric blood & cancer, 2023-08, Vol.70 (8), p.e30405-n/a

2023

Volltextzugriff (PDF)

High-Throughput Screening Identifies Idasanutlin as a Resensitizing Drug for Venetoclax-Resistant Neuroblastoma Cells

Molecular cancer therapeutics, 2021-06, Vol.20 (6), p.1161-1172

2021

Volltextzugriff (PDF)

Hyperleukocytosis in infant acute leukemia: a role for manual exchange transfusion for leukoreduction

Transfusion (Philadelphia, Pa.), 2018-05, Vol.58 (5), p.1149-1156

2018

Volltextzugriff (PDF)

Mentors’ perspectives on the successes and challenges of mentoring in the COG Young Investigator mentorship program: A report from the Children's Oncology Group

Pediatric blood & cancer, 2019-10, Vol.66 (10), p.e27920-n/a

2019

Volltextzugriff (PDF)

A 3D Bioprinted in vitro Model of Neuroblastoma Recapitulates Dynamic Tumor‐Endothelial Cell Interactions Contributing to Solid Tumor Aggressive Behavior (Adv. Sci. 23/2022)

Advanced science, 2022-08, Vol.9 (23), p.n/a

2022

Volltextzugriff (PDF)

1 – 25 von 107

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(96)

Publikationsform

Artikel
(105)
Berichte
(2)

Sprache

Englisch
(107)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Tumour-associated macrophages exhibit anti-tumoural properties in Sonic Hedgehog medulloblastoma

A New Player in Neuroblastoma: YAP and Its Role in the Neuroblastoma Microenvironment

YAP-Mediated Repression of HRK Regulates Tumor Growth, Therapy Response, and Survival Under Tumor Environmental Stress in Neuroblastoma

Children's Oncology Group's 2023 blueprint for research: Neuroblastoma

Circulating tumor DNA reveals mechanisms of lorlatinib resistance in patients with relapsed/refractory ALK-driven neuroblastoma

The yes-associated protein (YAP) is associated with resistance to anti-GD2 immunotherapy in neuroblastoma through downregulation of ST8SIA1

Dissecting the cellular components of ex vivo γδ T cell expansions to optimize selection of potent cell therapy donors for neuroblastoma immunotherapy trials

A 3D Bioprinted in vitro Model of Neuroblastoma Recapitulates Dynamic Tumor‐Endothelial Cell Interactions Contributing to Solid Tumor Aggressive Behavior

Mitochondrial Bcl-2 Family Dynamics Define Therapy Response and Resistance in Neuroblastoma

Favorable Local Control From Consolidative Radiation Therapy in High-Risk Neuroblastoma Despite Gross Residual Disease, Positive Margins, or Nodal Involvement

Ex vivo expanded patient-derived γδ T-cell immunotherapy enhances neuroblastoma tumor regression in a murine model

Identification of a Novel NRG1 Fusion with Targeted Therapeutic Implications in Locally Advanced Pediatric Cholangiocarcinoma: A Case Report

Phase II evaluation of sunitinib in the treatment of recurrent or refractory high‐grade glioma or ependymoma in children: a children's Oncology Group Study ACNS1021

Mcl1 downregulation sensitizes neuroblastoma to cytotoxic chemotherapy and small molecule Bcl2-family antagonists

Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results

Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium

Trends in analgesia‐sedation of pediatric patients receiving I‐131 MIBG in the pediatric intensive care unit: A report from the Pediatric Health Information System database

Select Bcl-2 antagonism restores chemotherapy sensitivity in high-risk neuroblastoma

A phase I study of sirolimus in combination with metronomic therapy (CHOAnome) in children with recurrent or refractory solid and brain tumors

Reduced ER–mitochondria connectivity promotes neuroblastoma multidrug resistance

A phase 1 study of simvastatin in combination with topotecan and cyclophosphamide in pediatric patients with relapsed and/or refractory solid and CNS tumors

High-Throughput Screening Identifies Idasanutlin as a Resensitizing Drug for Venetoclax-Resistant Neuroblastoma Cells

Hyperleukocytosis in infant acute leukemia: a role for manual exchange transfusion for leukoreduction

Mentors’ perspectives on the successes and challenges of mentoring in the COG Young Investigator mentorship program: A report from the Children's Oncology Group

A 3D Bioprinted in vitro Model of Neuroblastoma Recapitulates Dynamic Tumor‐Endothelial Cell Interactions Contributing to Solid Tumor Aggressive Behavior (Adv. Sci. 23/2022)

Suchergebnisse filtern